Tenderwize
Zurück zur Suche

Open House Discount Agreements for Sunitinib, ATC L01EX01

AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse·Eisenberg, Germany·Deadline Mar 31, 2027 · 218 days left·Open·Supplies
Structured notice only
Originaltitel der Bekanntmachung

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Sunitinib, ATC L01EX01

30/100

Opportunity Score

Needs reviewMedium complexity
SuppliesOpen
Warum diese Bewertung?

Chance

30 / 100

Komplexität

40 / 100

Risikofaktoren

No minimum volume or revenue guarantee. The buyer may replace open house agreements with exclusive contracts at any tim...

The notice explicitly states it is not a public procurement under EU directives, which may limit legal remedies in case...

Tiefe Portfolioanalyse

Tiefe Analyse der Unternehmenspassung

Verwendet:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Überblick

Moderate opportunity

Wichtige Fakten

  • Supplies contract
  • 1 lot
  • Duration until May 2027
  • Non-exclusive pharmaceutical discount agreements for Sunitinib (ATC L01EX01)
  • Open house model with uniform terms for all participants
Vollständige Zusammenfassung anzeigen

Open house non-exclusive discount agreements (Rabattverträge) for pharmaceutical products containing the active ingredient Sunitinib (ATC L01EX01) with the AOK Rheinland-Pfalz/Saarland. The open house model allows any interested pharmaceutical company to conclude a contract without a competitive selection process. The maximum contract duration is 24 months, with the earliest start on 01.06.2025 and all contracts ending by 31.05.2027. Contracts can be joined monthly. The buyer reserves the right to replace open house contracts with exclusive contracts awarded through EU-wide tenders. The notice states it is not a formal public procurement under EU directives, but published voluntarily for transparency.

Risiken

No minimum volume or revenue guarantee. The buyer may replace open house agreements with exclusive contracts at any tim...

The notice explicitly states it is not a public procurement under EU directives, which may limit legal remedies in case...

Analyse kann unvollständig sein

Nur ein Teil der Vergabeunterlagen wurde analysiert. Weitere Anforderungen, Zertifikate oder Einreichungsdokumente können in den übrigen Unterlagen enthalten sein.

Wichtige Anforderungen

Technical

  • Only authorized and marketable drugs in Germany (verified via Lauer-Taxe or AMIce database)
  • Proof of marketing authorization and pharmaceutical entrepreneur status

Administrative

  • Submission of signed contract documents by the deadline

Anforderungen können unvollständig sein.

Auftraggeber

Lose (1)

LOT-0001

Open House Discount Agreements for Sunitinib, ATC L01EX01

Non-exclusive discount agreements for Sunitinib drugs. All interested pharmaceutical companies can participate. Contract terms are uniform, no individual negotiations. First contract start on 01.06.2025, initial submission deadline 30.04.2025. Later contracts possible monthly until 31.03.2027. The open house agreements may be terminated early if the buyer concludes exclusive contracts.

SuppliesEU fundedElectronic submission

Ort

Eisenberg, Germany

Dauer

May 2025 - May 2027

Kategorie

Pharmaceutical products

Frist

Deadline Mar 31, 2027

Vergabedetails

Veröffentlichungsdatum
10 Apr 2025
Sprachen
German

Referenzmetadaten

Rechtsgrundlage
32014L0024

Referenz-IDs

Ausschreibungs-ID
235482-2025

Dokumente (1)

Ähnliche Ausschreibungen